Acute generalized exanthematous pustulosis induced by flupentixol-melitracen: a previously unreported drug reaction

Authors

  • Dipanjan Das Department of Dermatology, Jagannath Gupta Institute of Medical Sciences and Hospital, Budge, Kolkata, India
  • Lairenjam Teza Department of Dermatology, Jagannath Gupta Institute of Medical Sciences and Hospital, Budge, Kolkata, India
  • Asok Gangopadhyay Department of Dermatology, Jagannath Gupta Institute of Medical Sciences and Hospital, Budge, Kolkata, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20252588

Keywords:

SCADR, AGEP, Flupentixol-melitracen, Drug reaction

Abstract

Acute generalized exanthematous pustulosis (AGEP) is a rare and severe cutaneous drug reaction, most often triggered by antibiotics or antifungals. Psychotropic medications are an uncommon cause. We report the case of a 60-year-old male who developed AGEP within 24-48 hours of initiating flupentixol-melitracen, a fixed-dose antipsychotic-antidepressant combination. Clinical features included widespread sterile pustules on an erythematous base, and histopathology confirmed the diagnosis. The eruption resolved rapidly upon drug withdrawal and topical corticosteroids. To the best of our knowledge, this is the first reported case of AGEP induced by flupentixol-melitracen. Clinicians should consider this rare association when evaluating drug-induced pustular eruptions.

 

Metrics

Metrics Loading ...

Author Biography

Lairenjam Teza, Department of Dermatology, Jagannath Gupta Institute of Medical Sciences and Hospital, Budge, Kolkata, India

PGY3, Dept of Dermatology

References

Szatkowski J, Schwartz RA, Kapila R. Acute generalized exanthematous pustulosis (AGEP): A review and update. Int J Dermatol. 2017;56(9):1015-20.

Sidoroff A, Dunant A, Viboud C, Halevy S, Bouwes Bavinck JN, Naldi L, et al. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case–control study (EuroSCAR). Br J Dermatol. 2007;157(5):989-96. DOI: https://doi.org/10.1111/j.1365-2133.2007.08156.x

Britschgi M, Steiner UC, Schmid S, Depta JP, Senti G, Bircher A, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest. 2001;107(11):1433-41. DOI: https://doi.org/10.1172/JCI12118

Britschgi M, Pichler WJ. Immune mechanisms of drug hypersensitivity. Allergy. 2002;57(8):645-55. DOI: https://doi.org/10.1034/j.1398-9995.57.s72.15.x

Downloads

Published

2025-08-22

How to Cite

Das, D., Teza, L., & Gangopadhyay, A. (2025). Acute generalized exanthematous pustulosis induced by flupentixol-melitracen: a previously unreported drug reaction. International Journal of Basic & Clinical Pharmacology, 14(5), 863–865. https://doi.org/10.18203/2319-2003.ijbcp20252588